Coverage
-
November 02, 2026
A Maryland federal judge has refused to let a British healthcare company dodge a lawsuit alleging it stole trade secrets relating to a novel method of treating depression with psilocybin, the active ingredient in psychoactive mushrooms.
4 other articles on this case.
View all »